These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 6582303)
1. Tumor cytotoxicity of human macrophages after incubation with synthetic analogues of 2-lysophosphatidylcholine. Andreesen R; Osterholz J; Luckenbach GA; Costabel U; Schulz A; Speth V; Munder PG; Löhr GW J Natl Cancer Inst; 1984 Jan; 72(1):53-9. PubMed ID: 6582303 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of spontaneous and lymphokine activated human macrophage cytotoxicity by hyperthermia. Andreesen R; Osterholz J; Schulz A; Löhr GW Blut; 1983 Oct; 47(4):225-9. PubMed ID: 6616073 [TBL] [Abstract][Full Text] [Related]
3. Effect of platelet-activating factor on monocyte activation and production of tumor necrosis factor. Bonavida B; Mencia-Huerta JM; Braquet P Int Arch Allergy Appl Immunol; 1989; 88(1-2):157-60. PubMed ID: 2707879 [TBL] [Abstract][Full Text] [Related]
4. Anti-neoplastic action of peritoneal macrophages following oral administration of ether analogues of lysophospholipids. Ngwenya BZ; Fiavey NP; Mogashoa MM Eur J Cancer; 1992; 28A(10):1637-42. PubMed ID: 1389479 [TBL] [Abstract][Full Text] [Related]
5. Activation of peritoneal macrophages by orally administered ether analogues of lysophospholipids. Ngwenya BZ; Fiavey NP; Mogashoa MM Proc Soc Exp Biol Med; 1991 May; 197(1):91-7. PubMed ID: 1850526 [TBL] [Abstract][Full Text] [Related]
6. Activation of macrophages by ether analogues of lysophospholipids. Yamamoto N; Ngwenya BZ; Sery TW; Pieringer RA Cancer Immunol Immunother; 1987; 25(3):185-92. PubMed ID: 2824051 [TBL] [Abstract][Full Text] [Related]
7. The induction of lymphocytes with the capacity to render macrophages cytotoxic in an allogeneic murine system. De Weger RA; Pels E; Den Otter W Immunology; 1982 Nov; 47(3):541-50. PubMed ID: 6215342 [TBL] [Abstract][Full Text] [Related]
8. Effect of allogenic Dalton's lymphoma cells on the activation of murine peritoneal macrophages to tumoricidal state by cisplatin and lipopolysaccharide (LPS). Singh SM; Singh RK; Sodhi A Neoplasma; 1992; 39(3):151-5. PubMed ID: 1528319 [TBL] [Abstract][Full Text] [Related]
10. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor. Howard AD; Erickson KL Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340 [TBL] [Abstract][Full Text] [Related]
11. Selective activation of human monocytes by the platelet-activating factor analog 1-O-hexadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine. Rose JK; Debs RA; Philip R; Ruis NM; Valone FH J Immunol; 1990 May; 144(9):3513-7. PubMed ID: 2329280 [TBL] [Abstract][Full Text] [Related]
12. Tumoristatic effects of nonimmune BALB/c peritoneal macrophages on syngeneic lymphoma cells in vitro. Li J; Mansfield M; Wallace JH Oncology; 1977; 34(6):245-50. PubMed ID: 593652 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxic effector cell function at different stages of human monocyte-macrophage maturation. Andreesen R; Osterholz J; Bross KJ; Schulz A; Luckenbach GA; Löhr GW Cancer Res; 1983 Dec; 43(12 Pt 1):5931-6. PubMed ID: 6357433 [TBL] [Abstract][Full Text] [Related]
15. Killing of alveolar macrophages and of monocytes that have responded to granulocyte-macrophage colony-stimulating factor by human lymphokine-activated killer cells. Sone S; Inamura N; Singh SM; Okubo A; Yanagawa H; Nakanishi M; Ogura T Jpn J Cancer Res; 1989 Jul; 80(7):662-9. PubMed ID: 2507489 [TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of a piperidine phospholipid. Houlihan WJ; Lee ML; Munder PG; Handley DA; Nemecek GA; Jaeggi CS; Winslow CW Arzneimittelforschung; 1994 Dec; 44(12):1384-8. PubMed ID: 7848363 [TBL] [Abstract][Full Text] [Related]